The most public front was active last week, with the Senate passing a bill intended to make it easier for cheap generic drugs to come onto the market. The bill, sponsored by Sens. Charles Schumer, D-N.Y., and John McCain, R-Ariz., drew considerable support in Congress and strong opposition from the pharmaceutical industry.

















